← FDA Drug Approvals (Drugs@FDA)
IRINOTECAN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2019-11-18
Drug application
- FDA Application #
ANDA212993- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IRINOTECAN HYDROCHLORIDE
- Generic name
- IRINOTECAN HYDROCHLOIDE
- Active ingredients
- IRINOTECAN HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- GLAND
- Manufacturer
- BluePoint Laboratories
- First approval
- 2019-11-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown